Since its establishment in November 2004, the Sidney Kimmel Comprehensive Cancer Center (SKCCC) Microarray Core has provided services with affordable rates and flexibility in a timely manner to Cancer Center members across the Hopkins Medical Campus. The Core operates such that it supplies platforms not primarily offered by other array Cores throughout the School of Medicine and it is closely linked, for high level computational needs of users, to the new Bioinformatics Core in the Cancer Center. Since the last renewal, the Core has added to its full Agilent expression and DNA platforms, lllumina Infinium BeadChip technology including the Infinium platform for genome wide, promoter region DNA methylation. Thus, using both Agilent and lllumina technologies, the Core now offers assays for gene expression, micro RNA expression, DNA copy number variation, ChlP-on-chip, and genome-wide DNA methylation profiling. SNP analysis is also possible with the Core's current platforms. The probe density on the arrays and level of sample throughput have been increased significantly since the last renewal to efficiently meet the increased research needs of Cancer Center members. The Core's services also include DNA and RNA extraction from submitted samples, quality assessment of all submitted RNA and DNA samples, bisulfate treatment and quality control assessment of DNA for the Infinium methylation platform, and experiment design consultation. Real time PCR confirmation of expression array data is also provided. Preliminary data analysis and help in using software for data analysis are offered. The Core participates in computational biology seminars arranged by the Bioinformatics Core and arranges presentations by Agilent, lllumina, and other array offering companies to all Cancer Center and others throughout the School of Medicine. Lay: The Microarray Core provides different DNA microarray solutions to meet the needs of genomic research as well as related services including sample isolation and software training for data analysis.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
5P30CA006973-50
Application #
8559745
Study Section
Subcommittee G - Education (NCI)
Project Start
Project End
Budget Start
2013-05-01
Budget End
2014-04-30
Support Year
50
Fiscal Year
2013
Total Cost
$196,728
Indirect Cost
$75,288
Name
Johns Hopkins University
Department
Type
DUNS #
001910777
City
Baltimore
State
MD
Country
United States
Zip Code
21218
Woodard, Lauren E; Dennis, Cindi L; Borchers, Julie A et al. (2018) Nanoparticle architecture preserves magnetic properties during coating to enable robust multi-modal functionality. Sci Rep 8:12706
Shrestha, Eva; White, James R; Yu, Shu-Han et al. (2018) Profiling the Urinary Microbiome in Men with Positive versus Negative Biopsies for Prostate Cancer. J Urol 199:161-171
Gordy, James T; Luo, Kun; Francica, Brian et al. (2018) Anti-IL-10-mediated Enhancement of Antitumor Efficacy of a Dendritic Cell-targeting MIP3?-gp100 Vaccine in the B16F10 Mouse Melanoma Model Is Dependent on Type I Interferons. J Immunother 41:181-189
El-Diwany, Ramy; Soliman, Mary; Sugawara, Sho et al. (2018) CMPK2 and BCL-G are associated with type 1 interferon-induced HIV restriction in humans. Sci Adv 4:eaat0843
Kyker-Snowman, Kelly; Erlanger Avigdor, Bracha; Nasim, Mansoor et al. (2018) A primary breast cancer with distinct foci of estrogen receptor-alpha positive and negative cells derived from the same clonal origin as revealed by whole exome sequencing. Breast Cancer Res Treat 170:425-430
Christenson, Eric S; Antonarakis, Emmanuel S (2018) PARP inhibitors for homologous recombination-deficient prostate cancer. Expert Opin Emerg Drugs 23:123-133
Ambinder, Richard F (2018) A viral protein kinase drug target for tumors? J Clin Invest 128:2197-2198
Lee, Alice J; Montgomery, Madeline C; Patel, Rupa R et al. (2018) Improving Insurance and Health Care Systems to Ensure Better Access to Sexually Transmitted Disease Testing and Prevention. Sex Transm Dis 45:283-286
Bharathy, Narendra; Berlow, Noah E; Wang, Eric et al. (2018) The HDAC3-SMARCA4-miR-27a axis promotes expression of the PAX3:FOXO1 fusion oncogene in rhabdomyosarcoma. Sci Signal 11:
McGrath-Morrow, Sharon A; Ndeh, Roland; Helmin, Kathryn A et al. (2018) DNA methylation regulates the neonatal CD4+ T-cell response to pneumonia in mice. J Biol Chem 293:11772-11783

Showing the most recent 10 out of 2393 publications